Clinical Trial Update: I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 1/2 trial evaluating I5NP to prevent delayed graft function in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complications of Kidney Transplant
• Delayed Graft Function

Drugs mentioned

• I5NP (I5NP)

Snippet

Sponsor: Quark Pharmaceuticals | Conditions: Delayed Graft Function, Other Complication of Kidney Transplant | Phase 1, Phase 2 | Status: COMPLETED